Annual Meeting News

NEW YORK--(BUSINESS WIRE)--DWS Municipal Income Trust (NYSE: KTF) (the “Fund”) announced today the results of the Annual Meeting of Shareholders for the Fund held on September 19, 2025 at the offices of DWS Investment Management Americas, Inc., 100 Summer Street, Boston, Massachusetts. A quorum of shareholders was present and the Class II Trustee nominee (Ms. Catherine Schrand) and preferred share Trustee nominees (Mr. Keith R. Fox and Mr. Chad D. Perry) received a sufficient number of votes fr...

CHICAGO--(BUSINESS WIRE)--The Boards of Trustees of Nuveen S&P 500 Buy-Write Income Fund (NYSE: BXMX), Nuveen Dow 30℠ Dynamic Overwrite Fund (NYSE: DIAX), and Nuveen S&P 500 Dynamic Overwrite Fund (NYSE: SPXX) have approved a proposal to merge the funds. The proposed mergers, if approved by shareholders, would combine BXMX and DIAX into SPXX. The mergers are intended to create a larger fund with lower net operating expenses and increased trading volume on the exchange for common shares....

SMITHS FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX:WEED, NASDAQ:CGC) today urges its shareholders to vote ahead of the upcoming annual general and special meeting of shareholders (the “Meeting”) on September 26, 2025 at 1:00 PM ET. Canopy Needs Your Vote – Vote Today and Help Us Reach Quorum Canopy Growth is approaching number of shares needed to reach quorum for the Meeting and needs your help to reach this threshold to avoid delaying the...

CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), today announced the results of its annual general and special meeting of shareholders (the “Meeting”) held on September 16, 2025. At the Meeting, the number of directors of the Company for the ensuing year was fixed at seven (7) and the following nominees for election as directors of the Company were elected by a majority of votes cast by the shareholders virtually present or represe...

MILAN--(BUSINESS WIRE)--Newron Pharmaceuticals today announced its financial results and operational highlights for the half-year ended June 30, 2025....

MONTREAL--(BUSINESS WIRE)--Lomiko Metals Inc. (TSX.V: LMR) (“Lomiko” or the “Company”) is pleased to announce Patrick Robert as new strategic advisor to Lomiko, and new compensation for Directors under the 2025 Omnibus Equity Incentive Plan grants as well as a corporate update. As part of the annual short and long-term incentive program, as determined by the Board, Lomiko is announcing the grant of Restricted Share Units (“RSUs”) and Deferred Share Units (“DSUs”) to the Board in accordance with...

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Materna Medical, a women’s health company pioneering solutions to protect and restore pelvic floor health, announced the presentation of a new case series at the 2025 Society of Ob/Gyn Hospitalists (SOGH) Annual Clinical Meeting, which provides long-term follow-up data confirming the persistence of levator ani muscle avulsions and highlights the risk reduction potential of the Ellora™ Obstetrical System. Dr. Helai Hesham of Columbia University Irving Medi...

THOUSAND OAKS, Calif.--(BUSINESS WIRE)--Mandos Health to present new analyses in Niemann-Pick Disease Type C at the 2025 American Neurological Association Annual Meeting...

THOUSAND OAKS, Calif.--(BUSINESS WIRE)--Kolibri Global Energy Inc. (the “Company” or “Kolibri”) (TSX: KEI, NASDAQ: KGEI) announces that the Board of Directors of the Company received a requisition pursuant to section 167 of the Business Corporations Act (British Columbia) (the “Act”) from CDS & Co. on behalf of certain of its participants, themselves holding common shares of the Company as custodian on behalf of TFG Asset Management UK LLP, the beneficial owner of such shares. The requisiti...

MONTPELLIER, France--(BUSINESS WIRE)--Regulatory News: Medincell (Paris:MEDCL) General Assembly held on September 11, 2025, has approved the appointments of three new independent board members: Dr Sharon Mates, Dr. Charles Kunsch, and Dr. Pascal Touchon. Dr. Sharon Mates, PhD, is the co-founder and former Chair and CEO of Intra-Cellular Therapies, a CNS-focused biotech that developed the successful drug CAPLYTA®, acquired by Johnson & Johnson for $14.6 billion in April 2025. Dr. Charles Kun...